Article
Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT.
Current pharmaceutical design - 1 Jan 2006
Cirulli Anna, Loria Maria Paola, Dambra Porzia, Di Serio Francesca, Ventura Maria T, Amati Luigi, Jirillo Emilio, Sabbà Carlo
Abstract excerpt
Hereditary Hemorrhagic Telangiectasia (HHT) is a rare genetic disease characterized by mutations occurring in the endoglin and ALK-1, two receptors of transforming growth factor-beta1. From a pathogenic point of view, a possible involvement of the immune system in HHT has been suggested since a mononuclear cell infiltrate was found around the area of telangiectases. Up until now, no information has been available...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
